What is Rowheels?
Rowheels operates at the intersection of medical technology and ergonomic engineering, specializing in the development of advanced manual wheelchair wheels. Unlike conventional designs that rely on a pushing motion, the company's patented propulsion system utilizes a pulling mechanism. This biomechanical shift is engineered to mitigate the risk of chronic upper body injuries and improve posture for users, particularly those with paraplegia. By offering customizable wheel configurations and enhanced braking systems, Rowheels addresses a critical gap in the assistive technology market, providing a more efficient and health-conscious alternative to standard mobility equipment. The company's market position is defined by its commitment to evidence-based design and its focus on long-term musculoskeletal health for its user base.
How much funding has Rowheels raised?
Rowheels has raised a total of $1.5M across 1 funding round:
Private Equity
$1.5M
Private Equity (2015): $1.5M with participation from WISC Partners
Key Investors in Rowheels
WISC Partners
WISC Partners is an investment firm focused on providing strategic operating capital to entrepreneurs capable of addressing significant challenges, often leveraging academic research partnerships to drive corporate development.
What's next for Rowheels?
With the infusion of this recent capital, Rowheels is poised to transition into a more aggressive growth phase. The strategic focus will likely center on expanding manufacturing capabilities and broadening distribution channels to reach a wider demographic of mobility-impaired individuals. Furthermore, the company is expected to leverage its partnership with institutional investors to deepen its research and development efforts, potentially exploring new iterations of its propulsion technology. As the firm scales, the primary objective will be to solidify its brand as the gold standard for ergonomic mobility, ensuring that its unique value proposition—reducing physical strain while increasing independence—is integrated into clinical and consumer markets globally. The company's ability to maintain its technological edge will be the primary driver of its long-term enterprise value.
See full Rowheels company page
